Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Chronic Spotaneous Urticaria, Idiopathic Non Histaminergic Angioderma, Hereditary Angioedema With C1 Inhibitor Deficiency
and you are
between 18 and 80
years old
The phase for this study is not defined.
Show me locations

The purpose

Previous studies reported infraclinical modifications of the homeostasis in chronic urticaria, recurrent idiopathic angioedema and hereditary angioedema. This study aim to compare groups with isolated wheals, isolated angioedema, combination of both and hereditary angioedema in terms of coagulation pathways.

Provided treatments

  • Other: BLOOD TEST
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02892682. The sponsor of the trial is University Hospital, Montpellier and it is looking for 132 volunteers for the current phase.
Official trial title:
The Role of the Coagulation Pathways in Recurrent Angioedema